{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:43:57Z","timestamp":1792633437186,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jaip.2021.10.032","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T01:17:24Z","timestamp":1635383844000},"page":"S19-S30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"S","title":["2020 NAEPP Guidelines Update and GINA 2021\u2014Asthma Care Differences, Overlap, and Challenges"],"prefix":"10.1016","volume":"10","author":[{"given":"Bradley E.","family":"Chipps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.10.032_bib1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 Focused Updates to the Asthma Management Guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2008.09.029","article-title":"Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing","volume":"122","author":"Bacharier","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib4","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1056\/NEJMoa1104647","article-title":"Daily or intermittent budesonide in preschool children with recurrent wheezing","volume":"365","author":"Zeiger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0808907","article-title":"Preemptive use of high-dose fluticasone for virus-induced wheezing in young children","volume":"360","author":"Ducharme","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1651-2227.1999.tb01266.x","article-title":"Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers","volume":"88","author":"Svedmyr","year":"1999","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaip.2021.10.032_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jpeds.2004.04.007","article-title":"\u03b2-Agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis","volume":"145","author":"Castro-Rodriguez","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2021.10.032_bib8","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa054692","article-title":"Intermittent inhaled corticosteroids in infants with episodic wheezing","volume":"354","author":"Bisgaard","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/adc.65.4.407","article-title":"Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home","volume":"65","author":"Wilson","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaip.2021.10.032_bib10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa042552","article-title":"Daily versus as-needed corticosteroids for mild persistent asthma","volume":"352","author":"Boushey","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib11","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.10.032_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.10.032_bib14","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide-formoterol as needed in mild asthma","volume":"378","author":"O'Byrne","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib15","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-needed budesonide- formoterol versus maintenance budesonide in mild asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib16","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.10.032_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thoraxjnl-2013-203557","article-title":"Combination of budesonide\/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction","volume":"69","author":"Lazarinis","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2021.10.032_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(03)15384-6","article-title":"Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial","volume":"363","author":"Harrison","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.10.032_bib20","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bmj.312.7033.748","article-title":"Randomised comparison of guided self management and traditional treatment of asthma over one year","volume":"312","author":"Lahdensuo","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2021.10.032_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200904-0616OC","article-title":"Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial","volume":"180","author":"Oborne","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib22","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJMoa1714257","article-title":"Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations","volume":"378","author":"McKeever","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib23","first-page":"CD007524","article-title":"Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children","volume":"6","author":"Kew","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2021.10.032_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1183\/09031936.06.00105305","article-title":"Pharmacological strategies for self-management of asthma exacerbations","volume":"28","author":"Reddel","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.10.032_bib25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2018.2757","article-title":"Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma: a systemic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.10.032_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomized controlled trial","volume":"1","author":"Papi","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib27","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1378\/chest.130.6.1733","article-title":"Budesonide\/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma","volume":"130","author":"Bisgaard","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2021.10.032_bib28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jaci.2005.01.054","article-title":"Patterns of asthma control: a 3-year analysis of patient claims","volume":"115","author":"Stempel","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.200403-409OC","article-title":"Corticosteroid use after hospital discharge among high-risk adults with asthma","volume":"170","author":"Krishnan","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-6-13","article-title":"Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study","volume":"6","author":"Partridge","year":"2006","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib31","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rmed.2014.09.012","article-title":"The effect of fluticasone furoate\/umeclidinium in adult patients with asthma: a randomized, dose ranging study","volume":"109","author":"Lee","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib33","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.2015.13277","article-title":"Anticholinergic vs long-acting beta-agonist in combination with inhaled corticosteroids in black adults with asthma: the BELT randomized clinical trial","volume":"314","author":"Wechsler","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.10.032_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2011.06.004","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma","volume":"128","author":"Bateman","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(15)00031-4","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clinthera.2014.12.008","article-title":"Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A randomized trial","volume":"37","author":"Rajanandh","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2021.10.032_bib37","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.jaip.2019.03.019","article-title":"Tiotropium is efficacious in 6- to 17-year-olds with asthma, independent of T2 phenotype","volume":"7","author":"Szefler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunology Pract"},{"key":"10.1016\/j.jaip.2021.10.032_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1465-9921-12-38","article-title":"Overall asthma control achieved with budesonide\/formoterol maintenance and reliever therapy for patients on different treatment steps","volume":"12","author":"Bateman","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2021.10.032_bib40","doi-asserted-by":"crossref","first-page":"1701688","DOI":"10.1183\/13993003.01688-2017","article-title":"Budesonide\/formoterol maintenance and reliever therapy in adolescent patients with asthma","volume":"51","author":"Jorub","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.10.032_bib41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(08)61448-8","article-title":"Management of asthma based on exhaled nitric oxide in addition to guideline based treatment for inner-city adolescents and young adults: a randomized controlled trial","volume":"372","author":"Szefler","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.10.032_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaci.2006.10.021","article-title":"Addressing issues of asthma in inner-city children","volume":"119","author":"Busse","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ppul.20455","article-title":"Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study","volume":"41","author":"Fritsch","year":"2006","journal-title":"Pediatr Pulm"},{"key":"10.1016\/j.jaip.2021.10.032_bib45","first-page":"191","article-title":"Association between the Asthma Predictive Index and levels of exhaled nitric oxide in infants and toddlers with recurrent wheezing","volume":"111","author":"Balinotti","year":"2013","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.jaip.2021.10.032_bib46","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.amepre.2011.05.012","article-title":"Effectiveness of home-based, multi-trigger, multicomponent interventions with an environmental focus for reducing asthma morbidity: a community guide systematic review","volume":"41","author":"Crocker","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib47","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJMoa032097","article-title":"Results of a home-based environmental intervention among urban children with asthma","volume":"351","author":"Morgan","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1164\/rccm.201609-1966OC","article-title":"Preventing severe asthma exacerbations in children. a randomized trial of mite-impermeable bedcovers","volume":"196","author":"Murray","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib49","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1365-2222.1996.tb00521.x","article-title":"Domestic allergens in public places. II: dog (Can f1) and cockroach (Bla g 2) allergens in dust and mite, cat, dog and cockroach allergens in the air in public buildings","volume":"26","author":"Custovic","year":"1996","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib50","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0091-6749(99)70172-7","article-title":"School as a risk environment for children allergic to cats and a site for transfer of cat allergen to homes","volume":"103","author":"Almqvist","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib51","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.127.5.1565","article-title":"Effect of pet removal on pet\u00a0allergic asthma","volume":"127","author":"Shirai","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2021.10.032_bib52","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0091-6749(89)90006-7","article-title":"The effect of cat removal on allergen content in household-dust samples","volume":"83","author":"Wood","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0889-8561(03)00004-3","article-title":"Animal danders","volume":"23","author":"Erwin","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.10.032_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.anai.2012.09.019","article-title":"Environmental assessment and exposure reduction of rodents: a practice parameter","volume":"109","author":"Phipatanakul","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.2016.21048","article-title":"Effect of an integrated pest management intervention on asthma symptoms among mouse-sensitized children and adolescents with asthma: a randomized clinical trial","volume":"317","author":"Matsui","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.10.032_bib56","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0091-6749(99)70296-4","article-title":"Removal of cockroach allergen from inner-city homes","volume":"104","author":"Eggleston","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1183\/09031936.06.00074705","article-title":"The link between fungi and severe asthma: a summary of the evidence","volume":"27","author":"Denning","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.10.032_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1398-9995.2000.00250.x","article-title":"House-dust-mite allergen concentrations (Der f 1) and mold spores in apartment bedrooms before and after installation of insulated windows and central heating systems","volume":"55","author":"Hirsch","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib59","first-page":"309","article-title":"Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus\u2013sensitive asthmatic children","volume":"27","author":"Altintas","year":"1999","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2021.10.032_bib60","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0091-6749(94)70067-2","article-title":"Monoclonal antibody\u2013standardized cat extract immunotherapy: risk benefit effects from a double-blind placebo study","volume":"93","author":"Alvarez-Cuesta","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib61","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1398-9995.2005.00862.x","article-title":"Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma","volume":"60","author":"Ameal","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1398-9995.2003.00334.x","article-title":"Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients: a double blind placebo-controlled study","volume":"59","author":"Arvidsson","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib63","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1067\/mai.2002.124465","article-title":"Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients","volume":"109","author":"Basomba","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib64","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0091-6749(90)90160-6","article-title":"Double-blind, placebo controlled immunotherapy with mixed grass-pollen allergoids, IV: comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid","volume":"85","author":"Bousquet","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000301580","article-title":"Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response","volume":"153","author":"Gallego","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib66","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jaci.2006.07.043","article-title":"Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study","volume":"118","author":"Garcia-Robaina","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib67","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bmj.284.6312.306","article-title":"Failure of hyposensitisation in treatment of children with grass-pollen asthma","volume":"284","author":"Hill","year":"1982","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2021.10.032_bib68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0091-6749(90)90156-X","article-title":"Double-blind, placebo controlled rush immunotherapy with a standardized Alternaria extract","volume":"85","author":"Horst","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib69","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3892\/etm.2014.1469","article-title":"Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite allergic children with asthma","volume":"7","author":"Hui","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.11.036","article-title":"Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children","volume":"127","author":"Kuna","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib71","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1172\/JCI114532","article-title":"Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes","volume":"85","author":"Machiels","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2021.10.032_bib72","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1365-2222.2004.02056.x","article-title":"Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemi siifolia pollen: a double-blind, placebo-controlled study","volume":"34","author":"Mirone","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaci.2005.03.011","article-title":"IL-9 and c-Kit1 mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy","volume":"116","author":"Nouri-Aria","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib74","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.4049\/jimmunol.172.5.3252","article-title":"Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity","volume":"172","author":"Nouri-Aria","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib75","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0091-6749(84)90251-3","article-title":"Immunotherapy in cat-induced asthma: double-blind trial with evaluation of in\u00a0vivo and in\u00a0vitro responses","volume":"74","author":"Ohman","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib76","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1398-9995.1997.tb02157.x","article-title":"A\u00a01-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults","volume":"52","author":"Olsen","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-6749(84)80021-4","article-title":"Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis","volume":"73","author":"Ortolani","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib78","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0091-6749(86)90076-X","article-title":"Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy","volume":"78","author":"Reid","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jaci.2005.09.054","article-title":"Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma","volume":"117","author":"Roberts","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib80","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2222.2003.01735.x","article-title":"Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial","volume":"33","author":"Varney","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1067\/mai.2001.112027","article-title":"Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial","volume":"107","author":"Walker","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib82","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1398-9995.2005.00913.x","article-title":"A\u00a0double-blind, placebo controlled study of house dust mite immunotherapy in Chinese asthmatic patients","volume":"61","author":"Wang","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib83","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000327566","article-title":"Effect of one year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study","volume":"157","author":"Yukselen","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib84","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0091-6749(89)90020-1","article-title":"The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo controlled, randomized study","volume":"83","author":"Kuna","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib85","unstructured":"Lin SY, Azar A, Suarez-Cuervo C, Diette GB, Brigham E, Rice J, et al. The role of immunotherapy in the treatment of asthma. Comparative Effectiveness Review No. 196. (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No.290-2015-00006-I). AHRQ Publication No. 17(18)-EHC029-EF. Rockville, MD: Agency for Healthcare Research and Quality; March 2018. Accessed February 22, 2021. https:\/\/effectivehealthcare.ahrq.gov\/products\/asthma-immunotherapy\/research"},{"key":"10.1016\/j.jaip.2021.10.032_bib86","first-page":"231","article-title":"Safety and efficacy of specific sublingual immunotherapy in patients with asthma and allergy to Dermatophagoides pteronyssinus [in Spanish]","volume":"52","author":"G\u00f3mez Vera","year":"2005","journal-title":"Rev Alerg Mex"},{"key":"10.1016\/j.jaip.2021.10.032_bib87","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.10.032_bib88","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.rmed.2014.07.017","article-title":"SQ HDM SLIT tablet (ALK) in treatment of asthma\u2014post hoc results from a randomised trial","volume":"108","author":"de Blay","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib89","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/all.12791","article-title":"House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial","volume":"71","author":"Devillier","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib90","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.aller.2012.07.004","article-title":"The contribution of sublingual immunotherapy to the achievement of control in birch related mild persistent asthma: a real-life randomised trial","volume":"41","author":"Marogna","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2021.10.032_bib91","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.anai.2014.11.015","article-title":"SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms","volume":"114","author":"Mosbech","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib92","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib93","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/all.12188","article-title":"House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma","volume":"69","author":"Wang","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib94","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3833","article-title":"Allergen-specific immunotherapy in the treatment of pediatric asthma: a systematic review","volume":"141","author":"Rice","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.10.032_bib95","first-page":"CD001186","article-title":"Injection allergen immunotherapy for asthma","volume":"8","author":"Abramson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2021.10.032_bib96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40629-018-0059-x","article-title":"SCIT with high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups","volume":"27","author":"Klimek","year":"2018","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jaip.2021.10.032_bib97","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2013.2049","article-title":"Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review","volume":"309","author":"Lin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.10.032_bib98","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.anai.2018.05.019","article-title":"Efficacy of add-on sublingual immunotherapy for adults with asthma: a meta-analysis and systematic review","volume":"121","author":"Xu","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib99","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1398-9995.2006.01205.x","article-title":"Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials using the Cochrane Collaboration method","volume":"61","author":"Calamita","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.10.032_bib100","first-page":"CD011293","article-title":"Sublingual immunotherapy for asthma","volume":"8","author":"Normansell","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2021.10.032_bib101","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaci.2013.08.009","article-title":"Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma","volume":"132","author":"Wechsler","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.10.032_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2466-11-8","article-title":"Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial","volume":"11","author":"Thomson","year":"2011","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2021.10.032_bib103","doi-asserted-by":"crossref","unstructured":"D\u2019Anci KE, Lynch MP, Leas BF, Apter AJ, Bryant-Stephens T, Kaczmarek JL, et\u00a0al. Effectiveness and safety of bronchial thermoplasty in management of asthma. Comparative Effective Review No. 202. (Prepared by the ECRI Institute\u2013Penn Medicine Evidence-based Practice Center under Contract No. 290-2015-00005-I). AHRQ Publication No. 18-EHC0003-EF. Rockville, Md: Agency for Healthcare Research and Quality; December 2017. Accessed February 22, 2021. https:\/\/doi.org\/10.23970\/AHRQEPCCER202","DOI":"10.23970\/AHRQEPCCER202"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821011831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821011831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:34:44Z","timestamp":1761975284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821011831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213219821011831"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.10.032","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2020 NAEPP Guidelines Update and GINA 2021\u2014Asthma Care Differences, Overlap, and Challenges","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}